ICARES Medicus, Inc. (TPEX:6612)
127.50
+1.00 (0.79%)
Feb 21, 2025, 1:30 PM CST
ICARES Medicus Revenue
ICARES Medicus had revenue of 256.95M TWD in the quarter ending September 30, 2024, with 60.92% growth. This brings the company's revenue in the last twelve months to 742.27M, up 22.98% year-over-year. In the year 2023, ICARES Medicus had annual revenue of 605.45M with 18.29% growth.
Revenue (ttm)
742.27M
Revenue Growth
+22.98%
P/S Ratio
7.28
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.43B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 605.45M | 93.60M | 18.29% |
Dec 31, 2022 | 511.85M | 117.93M | 29.94% |
Dec 31, 2021 | 393.92M | 31.25M | 8.62% |
Dec 31, 2020 | 362.67M | -56.70M | -13.52% |
Dec 31, 2019 | 419.36M | 90.08M | 27.36% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 8.32B |
Caliway Biopharmaceuticals | 44.43M |
Bora Pharmaceuticals Co., LTD. | 16.71B |
Lotus Pharmaceutical | 17.59B |
Lumosa Therapeutics | 37.82M |
Oneness Biotech | 112.20M |
Polaris Group | 75.65M |
Pegavision | 7.06B |